[stock_market_widget type="clock-markets" template="analog" timezone="America/New_York" title="New York" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Europe/London" title="London" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Europe/Brussels" title="Brussels" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Asia/Hong_Kong" title="Hong Kong" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Asia/Tokyo" title="Tokyo" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Australia/Sydney" title="Sydney" style="font-size: 7px; width: 100px;"]

Stock Market News

Roche diagnostics head to become group CEO

07/21/2022

Less than a minute

2022.07.21 08:46

Roche diagnostics head to become group CEO
FILE PHOTO: A logo of Swiss pharmaceutical company Roche in Rotkreuz, Switzerland, April 12, 2012. REUTERS/Michael Buholzer

(Reuters) – Roche said the head of its diagnostics division, Thomas Schinecker, is to become group chief executive next year, replacing Severin Schwan, who will take the role of chairman of the board of directors.

Chairman Christoph Franz will not seek re-election after nine years as board chairman at the next annual shareholder meeting in March 2023, the Swiss drugmaker said in a statement on Thursday.

Source

07/21/2022

Less than a minute